Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01106183 · ClinicalTrials.gov registry record · NA

Efficacy of Transfer Factor to Prevent Upper Respiratory Tract Infections in Healthy Adults

A NA study of Upper Respiratory Tract Infections Due to Influenza or Rhinovirus, sponsored by University of Utah.

Completed
Registry status
NA
Development phase
49
Enrollment target
1
Study location

NCT01106183 is a NA study of Upper Respiratory Tract Infections Due to Influenza or Rhinovirus that has completed, run by University of Utah. The registered enrollment target is 49 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01106183, a NA study of Upper Respiratory Tract Infections Due to Influenza or Rhinovirus, has completed, sponsored by University of Utah.

COMPLETED
Registry status
NA
Development phase
49 participants
Enrollment target
1
Study location

Study Summary

The goals of our study are to critically evaluate if a healthy population supplemented with Transfer factor experiences fewer incidences of colds and flu, or experience shorter duration of illness compared to an identical population taking placebo. In this study we will give either Transfer factor or a placebo to two groups of healthy adult men and women for a period of 7 weeks in a double-blind experimental design. The frequency and duration of colds and flu-like symptoms will be recorded during the course of the study. Saliva samples will be collected weekly and assessed for salivary IgA secretion rate. Data from this study will establish the efficacy of Transfer Factor to support a healthy immune system.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT transfer factor

Study Locations (1)

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2010-01
Est. Completion 2010-03
Phase NA

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT01106183

The ClinicalTrials.gov registry entry for NCT01106183 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Upper Respiratory Tract Infections Due to Influenza or Rhinovirus appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01106183 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT01106183 about?

NCT01106183 is a clinical study titled "Efficacy of Transfer Factor to Prevent Upper Respiratory Tract Infections in Healthy Adults". The goals of our study are to critically evaluate if a healthy population supplemented with Transfer factor experiences fewer incidences of colds and flu, or experience shorter duration of illness compared to an identical population taking placebo. In this study we will give either Transfer factor o...

What is the current status of trial NCT01106183?

This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2010-01. Estimated completion is 2010-03.

What conditions does trial NCT01106183 study?

This clinical trial studies the following conditions: Upper Respiratory Tract Infections Due to Influenza or Rhinovirus.

What interventions are being tested in trial NCT01106183?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), transfer factor (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01106183?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01106183 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.